Statnews
Published November 16, 2026
Helus' psychedelic drug improved depression in study but faces safety questions
Read the full story at Statnews
A psychedelic drug candidate from Helus Pharma significantly helped people with major depression in a Phase 3 trial, the company said Monday,.
Surfaced by 2 Google Alerts
- Psychedelics
- Psychedelic biotech